thrombotic syndrome (RR, 0.67; 95%
CI, 0.52-0.87). Unfortunately, pooled analysis19 of these
nine trials yielded no reliable data regarding the risk of
complications or death. As with all strategies of early
thrombus removal, careful attention to patient selection
and an individual assessment of risks vs benefits as well as
patient values and preferences is required in recommending
iliofemoral ven